1. Home
  2. TENX vs TWIN Comparison

TENX vs TWIN Comparison

Compare TENX & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$11.87

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$16.73

Market Cap

269.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
TWIN
Founded
1967
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
269.7M
IPO Year
2001
1994

Fundamental Metrics

Financial Performance
Metric
TENX
TWIN
Price
$11.87
$16.73
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
545.5K
65.9K
Earning Date
05-15-2026
05-06-2026
Dividend Yield
N/A
0.98%
EPS Growth
N/A
N/A
EPS
N/A
1.76
Revenue
N/A
$340,738,000.00
Revenue This Year
N/A
$10.79
Revenue Next Year
N/A
$8.43
P/E Ratio
N/A
$9.82
Revenue Growth
N/A
15.45
52 Week Low
$5.34
$7.06
52 Week High
$18.38
$19.67

Technical Indicators

Market Signals
Indicator
TENX
TWIN
Relative Strength Index (RSI) 43.07 47.19
Support Level $10.87 $16.46
Resistance Level $12.75 $18.95
Average True Range (ATR) 0.67 1.08
MACD 0.06 -0.06
Stochastic Oscillator 51.11 35.48

Price Performance

Historical Comparison
TENX
TWIN

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: